Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

Mia Petljak(New York University), Michael R. Stratton(Wellcome Sanger Institute), Kathryn Beal(Wellcome Trust), Jonathan Brammeld(Wellcome Sanger Institute), Keiran Raine(Wellcome Sanger Institute), David Jones(European Bioinformatics Institute), Peter J. Campbell(Wellcome Sanger Institute), Sebastian Großmann(Wellcome Sanger Institute), Burçak Otlu(Middle East Technical University), Jennifer Graham(Wellcome Sanger Institute), Young Seok Ju(Kim's Eye Hospital), Bernardo Rodríguez–Martín(Universidade de Santiago de Compostela), José M. C. Tubío(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Ilias Georgakopoulos‐Soares(William Penn University), Ching Chiek Koh(University of Cambridge), Shriram G. Bhosle(Wellcome Sanger Institute), Serena Nik‐Zainal(University of Cambridge), Laura P. O’Neill(Wellcome Sanger Institute), Mark Maddison(Wellcome Sanger Institute), Stacey Price(Wellcome Sanger Institute), Ultan McDermott(AstraZeneca (United Kingdom)), Ludmil B. Alexandrov(UC San Diego Health System), Jorge Zamora(Universidade de Santiago de Compostela), Francesco Iorio(Human Technopole), Mathew J. Garnett(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), Nikita Patel(Emory University), Elizabeth Anderson(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Kevin J. Dawson(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), David C. Wedge(University of Manchester), Sarah O’Meara(Wellcome Sanger Institute), Bee Ling Ng(Wellcome Sanger Institute)
Cited by 446


Related Papers